In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol Drug Master File in Korea (Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol. The MFDS reviews the Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol KDMF as part of the drug registration process and uses the information provided in the Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aloperidin, Bioperidolo, Brotopon, Dozic, Haloperidol suppliers with KDMF on PharmaCompass.